Navigation Links
NEXCORE Technology Selected to Manufacture New Endoscopic Cryotherapy Device
Date:10/6/2008

WALDWICK, N.J., Oct. 6 /PRNewswire/ -- NEXCORE Technology, Inc., a world-class original equipment manufacturer (OEM) of medical devices, has reached an agreement with GI Supply of Camp Hill, Pa, for NEXCORE to manufacture GI Supply's revolutionary Polar Wand. Polar Wand is a portable device that uses endoscopic cryotherapy to control bleeding from mucosal lesions of the gastrointestinal tract in patients resistant to conventional endoscopic therapy.

NEXCORE is transitioning the product from industrial design to manufacturing.

Polar Wand distributes a freezing spray to treat bleeding in the GI tract. It is low cost, easy to operate and can target large areas. The Polar Wand was introduced in May and the product is now being shipped. The Bolt Group was the industrial designer.

"Without missing a beat, NEXCORE took the Bolt Group's design and quickly set up and tested the manufacturing process," said Frank Carter, CEO of GI Supply. "Their attention to us, understanding of our product and speed in getting the product to market was vital as we had lost valuable time when we started with another company."

According to Milton Frank, President and CEO of NEXCORE, "Our facilities are set up to take the industrial design provided by a client and quickly move into the manufacturing phase. In the case of the Polar Wand, it was important that we moved the product to market as quickly as possible without surrendering product integrity."

NEXCORE Technology is a world-class OEM medical device manufacturer specializing in complex diagnostic and therapeutic systems. It produces some of the industries most innovative products for numerous large and sophisticated medical device manufacturers, taking the specifications from concept through design and manufacturing to after-market services. For additional company information: http://www.nexcoretech.com

Contact: Judd Cohen

Cohen Communications

212-682-7838

judd@cohencom.net


'/>"/>
SOURCE NEXCORE Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NEXCORE Technology Obtains Licenses for Revolutionary Fluid Management System
2. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
3. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
4. Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners
5. New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS
6. Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology
7. Jacobs Receives Contract From Gedeon Richter for New Biotechnology Facility in Hungary
8. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2008 Washington State Technology Fast 50 for 5th Time in Past 7 Years
9. InNexus Biotechnology CEO to Present at BioContactQuebec 2008
10. Nomad Bioscience: New Plant Biotechnology Company Founded to Focus on Biomaterials and Biopharmaceuticals
11. DSM and Crucell Announce Another Key Achievement for PER.C6(R) Technology; Scale Up of High-Titer Fed-Batch Process to 250 Liters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mar 23, 2017 Research and Markets ... Markets" report to their offering. ... The Global Market for ... in 2016 at a CAGR of 8.9%, ... non-energetic bioproducts into seven major product segments: bio-derived chemicals, biofuels, ...
(Date:3/23/2017)... , March 23, 2017  SeraCare Life ... global in vitro diagnostics manufacturers and clinical ... industry,s first multiplexed Inherited Cancer reference ... by next-generation sequencing (NGS). The Seraseqâ„¢ Inherited ... with input from industry experts to validate ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
Breaking Biology Technology:
(Date:3/7/2017)... England , March 7, 2017 Brandwatch , ... chosen by The Prince,s Trust to uncover insights to ... across The Trust. The UK,s leading youth charity will ... social campaign results and get a better understanding of the topics ... ...
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
Breaking Biology News(10 mins):